Bavarian Nordic Thinks Big With Emergent Travel Vaccines Buy

With the money coming in from monkeypox product Jynneos, the Danish firm has decided to pursue its goal of becoming one of the largest pure-play vaccine companies by acquiring jabs for cholera and typhoid from Emergent.